In silico study of sulforaphane interaction with LasR of P. aeruginosa

TIRATSUYAN, S. G.; ANTONYAN, T. N.

Home
→
Facultatea Calculatoare, Informatică şi Microelectronică
→
Conferinţe
→
Conferinţa "Health Technology Management"
→
2016
→
View Item

dc.contributor.author	TIRATSUYAN, S. G.
dc.contributor.author	ANTONYAN, T. N.
dc.date.accessioned	2019-10-22T10:16:16Z
dc.date.available	2019-10-22T10:16:16Z
dc.date.issued	2016
dc.identifier.citation	TIRATSUYAN, S. G., ANTONYAN, T. N. In silico study of sulforaphane interaction with LasR of P. aeruginosa. In: Health Technology Management. Book of abstracts: proc. of the 3rd intern. conf., October 6-17, 2016. Chişinău, 2016, p. 43. ISBN 978-9975-51-774-4	en_US
dc.identifier.isbn	978-9975-51-774-4
dc.identifier.uri	http://repository.utm.md/handle/5014/4999
dc.description	Abstract	en_US
dc.description.abstract	One of the most important public health challenges of the 21st century is the search of new preventive or therapeutic anti-infective strategies, based on a combination of the plant-derived quorum-sensing inhibitors (QSI) with anti-inflammatory agents, and immunomodulators without pressure on the selection factors and the effect of dysbiosis [1]. Among the family Brassicaceae crucial secondary metabolites are isothiocyanates, such as sulforaphane (SFN), erucine etc. which have anticancer, anti-atherogenic, hepatoprotective, antimutagenic, antioxidant, antifungal, antibacterial, and bioherbicidal activities [2, 3].	en_US
dc.language.iso	en	en_US
dc.publisher	Tehnica UTM	en_US
dc.rights	Attribution-NonCommercial-NoDerivs 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.subject	anti-infective strategies	en_US
dc.subject	pathogen P. aeruginosa	en_US
dc.title	In silico study of sulforaphane interaction with LasR of P. aeruginosa	en_US
dc.type	Article	en_US